• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Choroidal Neovascularization Induces Retinal Edema and its Treatment Addresses this Problem.

作者信息

Tadayoni Ramin

机构信息

Department of Ophthalmology, Hôpital Lariboisière, AP-HP, Université Paris 7 - Sorbonne Paris Cité, Paris, France.

出版信息

J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):405-6. doi: 10.4103/2008-322X.150799.

DOI:10.4103/2008-322X.150799
PMID:25709762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4329697/
Abstract
摘要

相似文献

1
Choroidal Neovascularization Induces Retinal Edema and its Treatment Addresses this Problem.脉络膜新生血管形成可导致视网膜水肿，其治疗可解决这一问题。
J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):405-6. doi: 10.4103/2008-322X.150799.
2
Optical coherence tomographic features of idiopathic submacular choroidal neovascularization.
Am J Ophthalmol. 2000 Dec;130(6):763-8. doi: 10.1016/s0002-9394(00)00708-x.
3
Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier.sFlt-1的眼周基因转移可抑制眼内新生血管形成以及血管内皮生长因子诱导的血视网膜屏障破坏。
Hum Gene Ther. 2003 Jan 20;14(2):129-41. doi: 10.1089/104303403321070829.
4
The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser.
Ophthalmology. 1997 Dec;104(12):2030-8. doi: 10.1016/s0161-6420(97)30061-x.
5
Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.年龄相关性黄斑变性中的视网膜脉络膜吻合与隐匿性脉络膜新生血管形成
Ophthalmology. 2000 Apr;107(4):742-53; discussion 753-4. doi: 10.1016/s0161-6420(00)00009-9.
6
Blockade of nitric-oxide synthase reduces choroidal neovascularization.一氧化氮合酶的阻断可减少脉络膜新生血管形成。
Mol Pharmacol. 2002 Sep;62(3):539-44. doi: 10.1124/mol.62.3.539.
7
VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.血管内皮生长因子受体陷阱（R1R2）可抑制脉络膜新生血管形成以及血管内皮生长因子诱导的血视网膜屏障破坏。
J Cell Physiol. 2003 May;195(2):241-8. doi: 10.1002/jcp.10246.
8
[New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].[新型药物血管内皮生长因子受体融合蛋白眼用注射液（阿柏西普）及其在治疗年龄相关性黄斑变性、视网膜中央静脉阻塞、糖尿病性黄斑水肿和病理性近视继发脉络膜新生血管中的应用]
Klin Oczna. 2012;114(4):308-10.
9
Angiographic and flow patterns of retinal choroidal anastomoses in age-related macular degeneration with occult choroidal neovascularization.年龄相关性黄斑变性伴隐匿性脉络膜新生血管中视网膜脉络膜吻合的血管造影及血流模式
Ophthalmology. 2002 Sep;109(9):1726-36. doi: 10.1016/s0161-6420(02)01149-1.
10
Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.脉络膜毛细血管血流在治疗与年龄相关性黄斑变性相关的黄斑下脉络膜新生血管中作用的理论研究
Am J Ophthalmol. 2001 Jul;132(1):85-93. doi: 10.1016/s0002-9394(01)00872-8.

引用本文的文献

1
Safety and tolerability of intravitreal umedaptanib pegol (anti-FGF2) for neovascular age-related macular degeneration (nAMD): a phase 1, open-label study.抗 FGF2 单克隆抗体 Umedaptanib 聚乙二醇眼部注射治疗新生血管性年龄相关性黄斑变性（nAMD）的安全性和耐受性：一项 1 期、开放标签研究。
Eye (Lond). 2024 Apr;38(6):1149-1154. doi: 10.1038/s41433-023-02849-6. Epub 2023 Dec 1.
2
Safety and tolerability of oral vorolanib for neovascular (wet) age-related macular degeneration: a phase I, open-label study.口服沃罗替尼治疗新生血管性（湿性）年龄相关性黄斑变性的安全性和耐受性：一项I期开放标签研究。
Eye (Lond). 2023 Oct;37(15):3228-3233. doi: 10.1038/s41433-023-02496-x. Epub 2023 Apr 11.
3
Microbiota and Ocular Diseases.微生物组与眼部疾病
Front Cell Infect Microbiol. 2021 Oct 21;11:759333. doi: 10.3389/fcimb.2021.759333. eCollection 2021.
4
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD).新生血管性年龄相关性黄斑变性（nAMD）的新型创新治疗方法。
J Clin Med. 2021 May 30;10(11):2436. doi: 10.3390/jcm10112436.
5
Influence of gut microbiota on eye diseases: an overview.肠道微生物群对眼病的影响：概述。
Ann Med. 2021 Dec;53(1):750-761. doi: 10.1080/07853890.2021.1925150.
6
Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence.共生菌群引起的表观遗传变化是否会导致眼部疾病的发生？对证据的综述。
Hum Genomics. 2020 Mar 13;14(1):11. doi: 10.1186/s40246-020-00257-5.
7
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab.玻璃体内注射阿柏西普治疗先前接受过雷珠单抗治疗的新生血管性年龄相关性黄斑变性。
Int J Ophthalmol. 2017 Mar 18;10(3):423-426. doi: 10.18240/ijo.2017.03.15. eCollection 2017.

本文引用的文献

1
Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial.光动力疗法联合玻璃体内注射贝伐单抗对比联合或不联合曲安奈德治疗新生血管性年龄相关性黄斑变性：一项随机临床试验
J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):469-77. doi: 10.4103/2008-322X.150826.
2
Effect of intravitreal triamcinolone acetonide or bevacizumab on choroidal thickness in eyes with diabetic macular edema.玻璃体内曲安奈德或贝伐单抗对糖尿病性黄斑水肿眼脉络膜厚度的影响。
Invest Ophthalmol Vis Sci. 2014 Jun 6;55(6):3979-85. doi: 10.1167/iovs.14-14188.
3
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后灵长类动物眼睛的超微结构研究结果。
Am J Ophthalmol. 2007 Jun;143(6):995-1002. doi: 10.1016/j.ajo.2007.03.007. Epub 2007 Apr 23.
4
Intravitreal triamcinolone acetonide for exudative age related macular degeneration.玻璃体内注射曲安奈德治疗渗出性年龄相关性黄斑变性
Br J Ophthalmol. 2003 Apr;87(4):462-8. doi: 10.1136/bjo.87.4.462.
5
Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.玻璃体内注射曲安奈德可抑制激光诱导的大鼠脉络膜新生血管形成。
Arch Ophthalmol. 2001 Mar;119(3):399-404. doi: 10.1001/archopht.119.3.399.
6
Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.玻璃体内注射类固醇对亚人类灵长类动物实验性视网膜下新生血管形成的影响。
Arch Ophthalmol. 1985 May;103(5):708-11. doi: 10.1001/archopht.1985.01050050100026.